PALATIN TECHNOLOGIES, INC. Waiver of Right of Participation and Amendment to the Series B Common Stock Purchase WarrantsWaiver of Right of Participation and Amendment to the Series B Common Stock Purchase Warrants • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations
Contract Type FiledJune 28th, 2010 Company IndustryReference is made to that certain Securities Purchase Agreement (the “SPA”), dated as of February 24, 2010, by and between Palatin Technologies, Inc. (the “Company”) and the undersigned purchaser of the Company’s common stock, par value per share $0.01 (“Common Stock”), Series A Common Stock Purchase Warrant and Series B Common Stock Purchase Warrant (“Series B Warrant”). The Company is currently in discussions with certain institutional investors for the sale of Common Stock and warrants to purchase Common Stock on terms that have been disclosed to you by our placement agent, Rodman & Renshaw, LLC (the “Proposed Financing”).